Business Wire – Page 6 – n-Lorem

n-Lorem Foundation Announces New Publication in Trends in Molecular Medicine

Publication highlights the [...]

mikejaram2023-02-02T03:53:53-04:00

n-Lorem Foundation Notes Latest in Guidance From FDA on Developing ASO Drug Products for Patients With Nano-rare Diseases

Guidance issued by [...]

mikejaram2023-02-01T01:11:48-04:00

John Maraganore Joins the n-Lorem Foundation Team as Chair of Its Advisory Council

John Maraganore pledges [...]

mikejaram2023-02-01T01:12:06-04:00

n-Lorem Foundation Welcomes New Members, Jason Wood and Gene Yeo, to its Board of Directors

Newest members contribute [...]

mikejaram2023-02-01T01:12:15-04:00

n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer

Experienced research geneticist [...]

mikejaram2023-02-01T01:12:22-04:00

n-Lorem Foundation Announces Partnership with Nitto Avecia to Strengthen Development of Personalized Medicines for Patients with Ultra-Rare Diseases

World’s largest oligonucleotide [...]

mikejaram2023-02-01T01:12:30-04:00

n-Lorem Foundation Welcomes Frank J. Sasinowski to its Board of Directors

Accomplished leader involved [...]

mikejaram2023-02-02T03:56:08-04:00

n-Lorem Foundation Applauds FDA’s Important and Highly Constructive Guidance for Individualized ASO Treatments for Patients with Ultra-Rare Conditions

New FDA guidance [...]

mikejaram2023-02-01T01:12:45-04:00

n-Lorem Foundation, ChemGenes Announce Collaboration to Support Manufacturing of Individualized Treatments for Patients with Ultra-Rare Diseases

Foundation’s partnership with [...]

mikejaram2023-02-01T01:12:53-04:00

n-Lorem Foundation Celebrates One-Year Anniversary as First and Only Organization to Offer Free, Personalized Treatment to Ultra-Rare Disease Patients

Foundation received 50 [...]

mikejaram2023-02-01T01:13:38-04:00